A Novel Oral Natural Extract for the Treatment of Senile Purpura
NCT ID: NCT01183910
Last Updated: 2011-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2008-11-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Type I Collagen for Relieving Scleroderma
NCT00005675
A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
NCT05211830
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
NCT05156138
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
NCT00716014
Effects of Topical SLPI on Skin Wounds
NCT00005569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Calcium carbonate placebo pill
Placebo medication to treat the appearance of the skin in patients with senile purpura
Calcium Carbonate
Oral Tablet Taken Twice a Day
Nutraceutical
Patients take a novel, natural nutraceutical product to improve the appearance of the skin of patients with senile purpura
Citrus Bioflavanoid Blend
Pill Taken Twice a Day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Citrus Bioflavanoid Blend
Pill Taken Twice a Day
Calcium Carbonate
Oral Tablet Taken Twice a Day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nexgen Dermatologics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NEXGEN DERMATOLOGICS, INC.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JOSHUA M BERLIN, MD
Role: PRINCIPAL_INVESTIGATOR
STUDY PROTOCOL, INC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Berlin Center of Medical Aesthetics
Boynton Beach, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
021775
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.